Follow the 세니젠 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 세니젠 has recorded 28 public disclosures. Market capitalisation: €27.9bn. The latest transaction was reported on 10 July 2026 (Purchase). Among the most active insiders: 박정웅. Every trade is openly available.
26
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
10 ops.
Sell Volume
Fundamental score
Ranked 28,236 of 29,156 companies
12.7
score / 100
Value
12
Quality
13
FCF yld-14%
Earn yld-19%
EV/EBITDA·
ROE-39%
Gross mgn20%
Net mgn-38%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.